This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Telmo Graça, PhD
Head of mRNA Process Development at Lonza
Speaker

Profile

Telmo is Process and Technology Lead for mRNA at Lonza and a key member of the External Innovations team within Cell and Gene Therapies. He leads mRNA process and technology programs that transition capabilities from R&D into GMP and QC, while aligning R&D, operations, innovation, and commercial stakeholders to drive governed execution. His role includes shaping strategic, research, and licensing collaborations and advising the Global Strategy Group on technology, innovation, and investment decisions. Previously, Telmo led automated mRNA manufacturing platforms at CureVac SE. He holds a Master’s in Biological Engineering and a PhD in Immunology and Infectious Diseases.

Agenda Sessions

  • Advancing RNA Therapeutics through Process Innovation: mRNA and LNP Technologies Shaping the Future of in vivo CAR T Therapies

    4:45pm